Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
CHENGDU,China,April 12,2025-- SichuanKelun-Biotech Biopharmaceutical Co.,Ltd. (the "Company") today announced that results from a Phase 3 registrational clinical study evaluating the novel